Literature DB >> 12133981

Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses.

Jenny Kim1, Maria-Teresa Ochoa, Stephan R Krutzik, Osamu Takeuchi, Satoshi Uematsu, Annaliza J Legaspi, Hans D Brightbill, Diana Holland, William J Cunliffe, Shizuo Akira, Peter A Sieling, Paul J Godowski, Robert L Modlin.   

Abstract

One of the factors that contributes to the pathogenesis of acne is Propionibacterium acnes; yet, the molecular mechanism by which P. acnes induces inflammation is not known. Recent studies have demonstrated that microbial agents trigger cytokine responses via Toll-like receptors (TLRs). We investigated whether TLR2 mediates P. acnes-induced cytokine production in acne. Transfection of TLR2 into a nonresponsive cell line was sufficient for NF-kappa B activation in response to P. acnes. In addition, peritoneal macrophages from wild-type, TLR6 knockout, and TLR1 knockout mice, but not TLR2 knockout mice, produced IL-6 in response to P. acnes. P. acnes also induced activation of IL-12 p40 promoter activity via TLR2. Furthermore, P. acnes induced IL-12 and IL-8 protein production by primary human monocytes and this cytokine production was inhibited by anti-TLR2 blocking Ab. Finally, in acne lesions, TLR2 was expressed on the cell surface of macrophages surrounding pilosebaceous follicles. These data suggest that P. acnes triggers inflammatory cytokine responses in acne by activation of TLR2. As such, TLR2 may provide a novel target for treatment of this common skin disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133981      PMCID: PMC4636337          DOI: 10.4049/jimmunol.169.3.1535

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.

Authors:  D M Underhill; A Ozinsky; A M Hajjar; A Stevens; C B Wilson; M Bassetti; A Aderem
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

2.  The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense.

Authors:  M J Williams; A Rodriguez; D A Kimbrell; E D Eldon
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

3.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

Authors:  K E Balashov; D R Smith; S J Khoury; D A Hafler; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Regulation of interleukin 12 p40 expression through an NF-kappa B half-site.

Authors:  T L Murphy; M G Cleveland; P Kulesza; J Magram; K M Murphy
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

5.  IL-12 is a central mediator of acute graft-versus-host disease in mice.

Authors:  E Williamson; P Garside; J A Bradley; A M Mowat
Journal:  J Immunol       Date:  1996-07-15       Impact factor: 5.422

6.  IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease.

Authors:  C S Via; V Rus; M K Gately; F D Finkelman
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

7.  Polymorphonuclear leukocyte lysosomal release in response to Propionibacterium acnes in vitro and its enhancement by sera from inflammatory acne patients.

Authors:  G F Webster; J J Leyden; C C Tsai; P Baehni; W P McArthur
Journal:  J Invest Dermatol       Date:  1980-06       Impact factor: 8.551

8.  Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA).

Authors:  A Bucht; P Larsson; L Weisbrot; C Thorne; P Pisa; G Smedegård; E C Keystone; A Grönberg
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

9.  Efficacy of minocycline compared with tetracycline in treatment of acne vulgaris.

Authors:  C G Hubbell; E R Hobbs; T Rist; J W White
Journal:  Arch Dermatol       Date:  1982-12

10.  MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4.

Authors:  R Shimazu; S Akashi; H Ogata; Y Nagai; K Fukudome; K Miyake; M Kimoto
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more
  138 in total

1.  The Expression of Toll-like Receptors in Dermatological Diseases and the Therapeutic Effect of Current and Newer Topical Toll-like Receptor Modulators.

Authors:  Whitney Valins; Sadegh Amini; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-09

2.  Isolation and partial purification of macrophage- and dendritic cell-activating components from Mycoplasma arthritidis: association with organism virulence and involvement with Toll-like receptor 2.

Authors:  Barry C Cole; Hong-Hua Mu; Nathan D Pennock; Akira Hasebe; Fok V Chan; Leigh R Washburn; Morgan R Peltier
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  Propionibacterium acnes induces discogenic low back pain via stimulating nucleus pulposus cells to secrete pro-algesic factor of IL-8/CINC-1 through TLR2-NF-κB p65 pathway.

Authors:  Yucheng Jiao; Ye Yuan; Yazhou Lin; Zezhu Zhou; Yuehuan Zheng; Wenjian Wu; Guoqing Tang; Yong Chen; Jiaqi Xiao; Changwei Li; Zhe Chen; Peng Cao
Journal:  J Mol Med (Berl)       Date:  2018-11-06       Impact factor: 4.599

Review 4.  [Pathophysiology of acne].

Authors:  C Borelli; G Plewig; K Degitz
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

5.  Association between chronic inflammation and latent infection of Propionibacterium acnes in non-pyogenic degenerated intervertebral discs: a pilot study.

Authors:  Ye Yuan; Yong Chen; Zezhu Zhou; Yucheng Jiao; Changwei Li; Yuehuan Zheng; Yazhou Lin; Jiaqi Xiao; Zhe Chen; Peng Cao
Journal:  Eur Spine J       Date:  2017-10-31       Impact factor: 3.134

6.  An update on the role of the sebaceous gland in the pathogenesis of acne.

Authors:  Evgenia Makrantonaki; Ruta Ganceviciene; Christos Zouboulis
Journal:  Dermatoendocrinol       Date:  2011-01

Review 7.  Propionibacterium acnes: from commensal to opportunistic biofilm-associated implant pathogen.

Authors:  Yvonne Achermann; Ellie J C Goldstein; Tom Coenye; Mark E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

8.  Short lipopeptides specifically inhibit the growth of Propionibacterium acnes with dual antibacterial and anti-inflammatory action.

Authors:  Guang Yang; Jingyu Wang; Shengsheng Lu; Zhao Chen; Sheng Fan; Daiwei Chen; Huanxin Xue; Wenyuan Shi; Jian He
Journal:  Br J Pharmacol       Date:  2019-04-15       Impact factor: 8.739

Review 9.  Topical antibacterial therapy for acne vulgaris.

Authors:  Brigitte Dreno
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Production of superoxide anions by keratinocytes initiates P. acnes-induced inflammation of the skin.

Authors:  Philippe A Grange; Christiane Chéreau; Joël Raingeaud; Carole Nicco; Bernard Weill; Nicolas Dupin; Frédéric Batteux
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.